Phagocytosis and killing of cefazolin-exposed Staphylococci and Bacilli by mouse peritoneal macrophages

Area of Science:

• Immunology
• Microbiology
• Pharmacology

Background:

• Macrophages are key immune cells involved in pathogen clearance.
• Staphylococcus aureus and Bacillus subtilis are common bacterial pathogens.
• Cefazolin is an antibiotic used to treat bacterial infections.

Purpose of the Study:

• To investigate the effect of subinhibitory cefazolin on macrophage phagocytic and microbicidal activity.
• To assess the impact of cefazolin on macrophage morphology and ultrastructure.

Main Methods:

• Proteose peptone-induced macrophages from Balb/c mice were used for in vitro assays.
• Macrophage activity was tested against Staphylococcus aureus and Bacillus subtilis.
• Electron microscopy was employed to examine cell morphology.

Main Results:

• Enhanced phagocytosis (50-60%) and bacterial killing (99% in 2 hours) were observed with cefazolin.
• Electron microscopy confirmed phagocytic activity in both control and cefazolin-treated groups.
• No changes in peritoneal cell morphology or ultrastructure were detected, indicating cefazolin does not penetrate macrophages.

Conclusions:

• Subinhibitory concentrations of cefazolin can augment macrophage function against Gram-positive bacteria.
• Cefazolin's inability to penetrate macrophages preserves their cellular integrity.
• This suggests a potential adjunctive role for cefazolin in enhancing host defense mechanisms.